Massimo Moro

机构：Fondazione IRCCS Istituto Nazionale dei Tumori · ORCID：0000-0003-2562-4007

发表论文 130 篇 · 总被引 2024 次 · h-index 25

代表论文

• A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors (2023 · Communications Biology · 被引 36)
• Hybrid epithelial-mesenchymal status of lung cancer dictates metastatic success through differential interaction with NK cells (2024 · Journal for ImmunoTherapy of Cancer · 被引 25)
• Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy (2024 · Journal of Experimental & Clinical Cancer Research · 被引 19)
• Abstract 3571: The ITCC-P4 sustainable platform of fully characterized PDXs supports the preclinical proof-of-concept drug testing of high-risk pediatric tumor models (2023 · Cancer Research · 被引 5)
• Supplementary Tables from Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade (2023 · 被引 1)
• The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric Cancers (2026 · Cancer Research)